1. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells
    Zhiyang Wang et al, 2016, Tumor Biol. CrossRef
  2. Upregulation of miR-192 inhibits cell growth and invasion and induces cell apoptosis by targeting TCF7 in human osteosarcoma
    Yadong Wang et al, 2016, Tumor Biol. CrossRef
  3. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated
    Lei Yin et al, 2016, Tumor Biol. CrossRef
  4. Autophagy-Regulating microRNAs and Cancer
    Devrim Gozuacik et al, 2017, Front. Oncol. CrossRef
  5. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma
    Ren-zeng Li et al, 2016, World J Surg Onc CrossRef
  6. Identification of Autophagy-Related Genes and Their Regulatory miRNAs Associated with Celiac Disease in Children
    Sergio Comincini et al, 2017, IJMS CrossRef
  7. Current updates on microRNAs as regulators of chemoresistance
    Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  8. MicroRNAs play big roles in modulating macrophages response toward mycobacteria infection
    Abualgasim Elgaili Abdalla et al, 2016, Infection, Genetics and Evolution CrossRef
  9. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy
    Dan Chen et al, 2017, Tumour Biol. CrossRef
  10. MicroRNA as a Therapeutic Target in Cardiac Remodeling
    Chao Chen et al, 2017, BioMed Research International CrossRef
  11. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy
    Jianliang Chen et al, 2017, J. Cell. Mol. Med. CrossRef
  12. Autophagy and doxorubicin resistance in cancer.
    Chao Chen et al, 2018, Anticancer Drugs CrossRef
  13. Autophagy as a potential target for sarcoma treatment
    Li Min et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  14. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1
    Haibin Yan et al, 2018, Anti-Cancer Drugs CrossRef
  15. MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1
    Quanxiang Liu et al, 2018, BioMed Research International CrossRef
  16. Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis
    Lin Xie et al, 2018, Cell Death Dis CrossRef
  17. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance
    Rongrong Liao et al, 2018, Mol Biol Rep CrossRef
  18. Chondrosarcoma: An Overview of Clinical Behavior, Molecular Mechanisms Mediated Drug Resistance and Potential Therapeutic Targets
    Elahe Nazeri et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
  19. The multifaceted role of autophagy in cancer and the microenvironment
    Hendrik Folkerts et al, 2018, Med Res Rev CrossRef
  20. SIAH1/ZEB1/IL-6 axis is involved in doxorubicin (Dox) resistance of osteosarcoma cells
    Xiuxin Han et al, 2018 CrossRef
  21. Maternal pentachlorophenol exposure induces developmental toxicity mediated by autophagy on pregnancy mice
    Xiaomin Huang et al, 2019, Ecotoxicology and Environmental Safety CrossRef
  22. Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
    Ruiling Chen et al, 2019, J Cell Mol Med CrossRef
  23. Role of autophagy in osteosarcoma.
    Olivier Camuzard et al, 2019, J Bone Oncol CrossRef
  24. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
  25. microRNA‐30a inhibits the liver cell proliferation and promotes cell apoptosis through the JAK/STAT signaling pathway by targeting SOCS‐1 in rats with sepsis
    Feng‐Hua Yuan et al, 2019, J Cell Physiol CrossRef
  26. MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3
    Haiyang Yu et al, 2019, Biosci. Rep. CrossRef
  27. Epigenetic Modifications of Autophagy in Cancer and Cancer Therapeutics
    Chandra S. Bhol et al, 2019, Seminars in Cancer Biology CrossRef
  28. The microRNA in ventricular remodeling: the miR-30 family
    Xiaonan Zhang et al, 2019, Biosci. Rep. CrossRef
  29. Autophagy: A novel mechanism of chemoresistance in cancers
    Xinyu Li et al, 2019, Biomedicine & Pharmacotherapy CrossRef
  30. MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells
    Chunying Li et al, 2016, Med Sci Monit CrossRef
  31. Regulation of multidrug resistance by microRNAs in anti-cancer therapy
    Xin An et al, 2017, Acta Pharmaceutica Sinica B CrossRef
  32. null
    Liuxi Chen et al, 2017 CrossRef
  33. Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in Diffuse Large B-cell Lymphoma: A Meta-Analysis
    Choo-Yuen Ting et al, 2019, Critical Reviews in Oncology/Hematology CrossRef
  34. Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer’s disease
    Soheil Madadi et al, 2019, Cell Biosci CrossRef
  35. Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication.
    Jianfang Niu et al, 2019, Front Oncol CrossRef
  36. Downregulation of microRNA-30a-5p contributes to the replication of duck enteritis virus by regulating Beclin-1-mediated autophagy
    Xianglong Wu et al, 2019, Virol J CrossRef
  37. MicroRNAs as major regulators of the autophagy pathway
    Yunus Akkoc et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  38. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy
    Zeinab Jamali et al, 2020, IUBMB Life CrossRef
  39. The molecular mechanisms of chemoresistance in cancers
    Hua-Chuan Zheng, 2017, Oncotarget CrossRef
  40. Noncoding RNA in drug resistant sarcoma
    Xiaoyang Li et al, 2017, Oncotarget CrossRef
  41. Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
    Franz Geisslinger et al, 2020, Front. Oncol. CrossRef
  42. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
    Yu‑Xin Liao et al, 2019, Int J Oncol CrossRef
  43. Rapamycin‑induced miR‑30a downregulation inhibits senescence of VSMCs by targeting Beclin1
    Pan Tan et al, 2019, Int J Mol Med CrossRef
  44. null
    Assirbad Behura et al, 2020 CrossRef
  45. Regulatory Effects of noncoding RNAs on the interplay of oxidative stress and autophagy in cancer malignancy and therapy
    Pei-Feng Liu et al, 2020, Seminars in Cancer Biology CrossRef
  46. Recent Insights into Therapy Resistance in Osteosarcoma
    Zachary D. Prudowsky et al, 2020, Cancers CrossRef
  47. The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer.
    Mengya Wang et al, 2021, PeerJ CrossRef
  48. A 10-year bibliometric analysis of osteosarcoma and cure from 2010 to 2019
    Wacili Da et al, 2021, BMC Cancer CrossRef
  49. MiR-30a sensitized lung cancer against neoadjuvant chemotherapy by depressing autophagy
    Xiao Lin et al, 2021 CrossRef
  50. Noncoding RNAs in osteosarcoma: Implications for drug resistance
    Zhengjun Lin et al, 2021, Cancer Letters CrossRef
  51. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
    Zhaopeng Tang et al, 2021, Technol Cancer Res Treat CrossRef
  52. Endothelial cell autophagy in chronic intermittent hypoxia is impaired by miRNA‐30a‐mediated translational control of Beclin‐1
    Rongrong Bi et al, 2019, J Cell Biochem CrossRef
  53. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma
    Foroogh Hosseini et al, 2021, Biochemical Pharmacology CrossRef
  54. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
    Zahra Torki et al, 2021, Cancer Chemother Pharmacol CrossRef
  55. null
    Edith Bonnelye, 2022 CrossRef
  56. Autophagy and apoptosis cascade: which is more prominent in neuronal death?
    Rohan Gupta et al, 2021, Cell. Mol. Life Sci. CrossRef
  57. microRNAs in cancer chemoresistance: The sword and the shield
    Priya Mondal et al, 2021, Non-coding RNA Research CrossRef
  58. Beclin1-mediated interplay between autophagy and apoptosis: New understanding
    Kumari Prerna et al, 2022, International Journal of Biological Macromolecules CrossRef
  59. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy
    Yuhe Lei et al, 2022, Front. Oncol. CrossRef
  60. Role of autophagy in drug resistance and regulation of osteosarcoma (Review)
    Yanchuan Pu et al, 2022, Mol Clin Oncol CrossRef
  61. Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components
    Entaz Bahar et al, 2022, Cancers CrossRef
  62. Circular RNA circMRPS35 regulates progression and autophagy in osteosarcoma cells by recruiting KAT6B to govern FOXO3
    Chunshan Jiang et al, 2022 CrossRef
  63. null
    Javid Sadri Nahand et al, 2022 CrossRef
  64. Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.
    Jiang-Hua Dai et al, 2019, Cell Cycle CrossRef
  65. Advances in the Biological Functions and Mechanisms of miRNAs in the Development of Osteosarcoma
    Zihe Dong et al, 2022, Technol Cancer Res Treat CrossRef
  66. Heart failure and cancer: From active exposure to passive adaption
    Yantao Du et al, 2022, Front. Cardiovasc. Med. CrossRef
  67. Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
    Lei Yu et al, 2022, Front. Immunol. CrossRef
  68. The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review
    Victoria L. Tippett et al, 2022, Oncogene CrossRef
  69. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
    Feng Shu et al, 2023, Sig Transduct Target Ther CrossRef
  70. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55
    Linhai Fu et al, 2023, Biochem Genet CrossRef
  71. null
    Farbod Bahreini et al, 2023 CrossRef
  72. Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response
    Mustafa M. Kadhim et al, 2023, Pharmacological Research CrossRef
  73. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
    Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
  74. Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy
    Jing Ye et al, 2023, Acta Pharmaceutica Sinica B CrossRef
  75. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
    Hefen Chen et al, 2024, Drug Development Research CrossRef
  76. Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
    Qiang Yu et al, 2024, Cancer Letters CrossRef